MIRAE ASSET SECURITIES (USA) INC.’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-113,276
Closed -$2.93M – 216
2025
Q3
$2.93M Buy
+113,276
New +$3.16M 0.09% 112
2025
Q1
– Sell
-200,547
Closed -$8.34M – 243
2024
Q4
$8.34M Buy
+200,547
New +$9.59M 0.25% 81

Other funds holding MRNA

MIRAE ASSET SECURITIES (USA) INC.'s MRNA Position: Q4 2025 in Review

MIRAE ASSET SECURITIES (USA) INC. sold out of Moderna (MRNA) in Q4 2025, closing a stake of 113,276 shares — an estimated $2.93M sold.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in MRNA in Q4 2024 and held it in 2 quarters. The position peaked at $8.34M in Q4 2024. 675 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • MIRAE ASSET SECURITIES (USA) INC. reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • MIRAE ASSET SECURITIES (USA) INC. sold 113,276 Moderna shares in Q4 2025, an estimated $2.93M.
  • MIRAE ASSET SECURITIES (USA) INC. first reported a position in Moderna in Q4 2024 and held it in 2 quarters.
  • MIRAE ASSET SECURITIES (USA) INC.'s Moderna position peaked at $8.34M in Q4 2024.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q4 2025, filed 11 Feb 2026.